Massive Update Reveals Multiple New Areas and Exciting Challenges for ‘MIR4’
Wemade performed a substantial update today to its widely acclaimed MMORPG, ‘MIR4’. Along with the introduction of new areas, Rockcut Tomb and Bladehaven, further changes include: an increase to the maximum character growth from Level 130 to Level 150, the addition of a new Boss Raid Clan Expedition as well as an expansion to Constitution and Inner Force.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220502005953/en/
Wemade performed a substantial update to its widely acclaimed MMORPG, MIR4. Along with the introduction of new areas, Rockcut Tomb and Bladehaven, further changes include: an increase to the maximum character growth from Level 130 to Level 150, the addition of a new Boss Raid Clan Expedition as well as an expansion to Constitution and Inner Force. (Graphic: Business Wire)
Rockcut Tomb and Bladehaven are ancient ruined hunting grounds located in the eastern part of the Phantasia Area. The addition of these new areas allows players to enjoy more diverse contents through enriched quests, stories, and missions. Additionally, a new area will be opened within Sabuk, including Sabuk Castle where a new dynamic story will unfold!
Along with the increase to the maximum character level from Level 130 to Level 150, the maximum Promotion Level for all Conquest buildings has increased to 19. By upgrading the Conquest Tower to 19, it is possible to reach the maximum level of 150.
In other changes, Constitution and Inner Force has been expanded to Tier 15 and 14 respectively, and there have been some new additions, including the new Mysteries ‘Wedding Vow’, the new boss fight ‘Deranged Hellbound Revenant’ and Clan Expedition ‘Azure Flame Emperor’, both of which can be challenged by users at Level 90 or higher. This extensive update allows players to unlock the full potential of their characters.
‘MIR4’ was released in August 2021 and since then, it has broken many records with over 200 servers and more than 1.4 million global concurrent users. The game’s economy continues to grow through the introduction of unique systems such as MIRAGE, an NFT character staking game, as well as HYDRA Payment which utilizes HYDRA, a DeFi utility token for ‘MIR4’, to purchase goods in the game. The present update offers players a plethora of content to enjoy, while upcoming additions will introduce a new transcendent boss named ‘Violet Demon God Turkan’ which will require large numbers of players to defeat.
‘MIR4’ continues to add new fun content and strives to evolve and grow the game’s economy. Visit MIR4 Global to find more information on these exciting updates and new challenges.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005953/en/
Contact information
Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee, PR Manager
yeonghyun@wemade.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stafford Establishes Timberland Continuation Fund at USD 1.2 billion4.12.2025 11:53:00 EET | Press release
Stafford Capital Partners (“Stafford”) today announced it has established a USD 1.2 billion continuation vehicle, the Stafford International Timberland Continuation Fund (The Continuation Fund or The Fund), marking a significant milestone in the firm’s strategic management of its timberland holdings. The Continuation Fund is a "roll-up" of three of Stafford’s existing core timberland funds – Stafford International Timberland funds VI, VII and VIII – into a new perpetual fund that will hold 74 high-quality core timberland assets. The fully-deployed portfolio took Stafford seven years to construct and holds interests in over 6.3m acres of commercial timberland in the USA, New Zealand, Australia and Latin America. This includes a number of assets that are seen as key strategic holdings in these regions where high-quality assets can be tightly held. The Fund holds positions in the 2nd and 3rd largest commercial timberlands estates in New Zealand, one of Australia’s largest softwood forest
Smartstream Introduces Agentic AI ‘Smart Agents’ for Investigations and Exceptions Handling4.12.2025 10:55:00 EET | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces the preview of Smart Agents for Investigations, a breakthrough in financial operations that brings augmented and autonomous exception handling to reconciliations and back-office processes. The new investigation agent combines domain-trained AI agents, workflow adoption, and embedded controls to triage, investigate, resolve, and learn from exceptions - reducing manual effort, accelerating time to resolution, and strengthening auditability. It will add a layer of intelligence on top of Smartstream’s current reconciliations and exceptions solutions. It understands the breaks context, adheres to customer playbooks and reaches out for missing information. It documents every step for audit and compliance, allowing analysts to focus on risk. Finally, it augments the analyst’s investigation with contextual information radically changing the user experience to review and a
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes4.12.2025 10:00:00 EET | Press release
LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with Sanofi. This collaboration combines LabGenius’ AI/ML-driven antibody design capabilities with Sanofi’s expertise in the development of therapeutic NANOBODY® molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA™ platform to optimise NANOBODY® molecules for multiple new targets in the area of inflammation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204759388/en/ “We are truly excited about this new collaboration with Sanofi,”said LabGenius’ CSO, Dr. Angus Sinclair. “This partnership serves as strong validation of our platform’s unique ability to tackle complex antibody co-optimisation challenges across
GoWit One: The Unified AI Operating System Set to Revolutionize Commerce & Retail Media4.12.2025 08:09:00 EET | Press release
GoWit, a global AdTech leader in omnichannel Commerce and Retail Media, announced the launch of GoWit One, the unified AI operating system that brings automation, unification, and real-time intelligence into a single ad platform for agencies operating across multiple retailers, channels, and markets. By bringing these three elements into one dashboard, GoWit One addresses the industry's most critical bottleneck: operational inefficiency. The platform enables agencies to manage campaigns across multiple retailers, channels, and markets, reducing manual AdOps workflows by 98%, turning a process that used to take hours into as little as 10 minutes. Solving the “Fragmentation Crisis” Despite the explosive growth of Retail Media, the industry faces a significant hurdle. According to the IAB, 70% of the market still lacks end-to-end AI adoption. Media buyers are currently forced to juggle disconnected networks, compliance rules, and dashboards, leading to manual errors and an inability to sc
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings4.12.2025 08:00:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook. The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. S&P notes the company’s well-established brand portfolio, global footprint, including an expanding presence in emerging markets, and continued investment in science-based innovation. S&P highlights momentum from recent launches, including Nemluvio® (nemolizumab), alongside improving profitability and expanding free operating cash flow. The agency also notes Galderma’s disciplined financial policy, supporting expectations of continued deleveraging over the coming years. The positive outlook indicates that an upgrade could be considered over the next 12–24 months subject to Galderma continuing to deliver profitable g
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom